Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Risk factors for chemotherapy-induced peripheral neuropathy in patients receiving taxane- and platinum-based chemotherapy.

Molassiotis A, Cheng HL, Leung KT, Li YC, Wong KH, Au JSK, Sundar R, Chan A, Ng TR, Suen LKP, Chan CW, Yorke J, Lopez V.

Brain Behav. 2019 Jun;9(6):e01312. doi: 10.1002/brb3.1312. Epub 2019 May 7.

2.

Minimal clinically important difference of the EORTC QLQ-CIPN20 for worsening peripheral neuropathy in patients receiving neurotoxic chemotherapy.

Yeo F, Ng CC, Loh KWJ, Molassiotis A, Cheng HL, Au JSK, Leung KT, Li YC, Wong KH, Suen L, Chan CW, Yorke J, Farrell C, Bandla A, Ang E, Lopez V, Sundar R, Chan A.

Support Care Cancer. 2019 Apr 10. doi: 10.1007/s00520-019-04771-8. [Epub ahead of print]

PMID:
30972646
3.

Living with chemotherapy-induced peripheral neuropathy: Uncovering the symptom experience and self-management of neuropathic symptoms among cancer survivors.

Chan CW, Cheng H, Au SK, Leung KT, Li YC, Wong KH, Molassiotis A.

Eur J Oncol Nurs. 2018 Oct;36:135-141. doi: 10.1016/j.ejon.2018.09.003. Epub 2018 Sep 27.

PMID:
30322504
4.

Intelligent Ball Bearing Fault Diagnosis Using Fractional Lorenz Chaos Extension Detection.

Tian AH, Fu CB, Li YC, Yau HT.

Sensors (Basel). 2018 Sep 12;18(9). pii: E3069. doi: 10.3390/s18093069.

5.

Osimertinib or Platinum-Pemetrexed in EGFR T790M-Positive Lung Cancer.

Mok TS, Wu Y-L, Ahn M-J, Garassino MC, Kim HR, Ramalingam SS, Shepherd FA, He Y, Akamatsu H, Theelen WS, Lee CK, Sebastian M, Templeton A, Mann H, Marotti M, Ghiorghiu S, Papadimitrakopoulou VA; AURA3 Investigators.

N Engl J Med. 2017 Feb 16;376(7):629-640. doi: 10.1056/NEJMoa1612674. Epub 2016 Dec 6.

Supplemental Content

Loading ...
Support Center